Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)
- 1 February 2009
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 75 (112), S20-S24
- https://doi.org/10.1038/ki.2008.613
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura: A Report From the SERF-TTP Research Group and the RADAR ProjectJournal of the American College of Cardiology, 2007
- Clopidogrel (Plavix) desensitization: A case seriesCatheterization and Cardiovascular Interventions, 2005
- Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heartProstaglandins, Leukotrienes & Essential Fatty Acids, 2005
- Clopidogrel-Associated TTPStroke, 2004
- TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology.Transplantation, 2002
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Thrombotic thrombocytopenic purpura related to ticlopidineThe Lancet, 1991
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPAThe Lancet, 1966